• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过下调TGF-β/Smad2/3信号通路抑制人甲状腺乳头状癌BCPAP细胞的转移。

Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.

作者信息

Zhang Li, Cheng Xian, Gao Yanyan, Zhang Chiyu, Bao Jiandong, Guan Haixia, Yu Huixin, Lu Rongrong, Xu Qiang, Sun Yang

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, China.

Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, China.

出版信息

Exp Cell Res. 2016 Feb 15;341(2):157-65. doi: 10.1016/j.yexcr.2016.01.006. Epub 2016 Jan 27.

DOI:10.1016/j.yexcr.2016.01.006
PMID:26826337
Abstract

Thyroid cancers usually possess a good prognosis while the risks of recurrence and metastasis turn out to be a disturbing issue. Curcumin [bis(4-hydroxy-3-methoxy-phenyl)-1,6-heptadiene-3,5-dione] is a natural polyphenolic compound mainly found in turmeric (Curcuma longa). Our previous studies have demonstrated that curcumin showed proliferation-inhibitory and apoptosis-inducing effects on K1 papillary thyroid cancer cells. However, the mechanism underlying the inhibition effects of curcumin on thyroid cancer cells remains unclear. Herein, we demonstrated that curcumin remarkably increased the expression of the epithelial marker E-cadherin and repressed the expression of the mesenchymal marker vimentin in human papillary thyroid carcinoma BCPAP cells. Curcumin also suppressed multiple metastatic steps of BCPAP cells, including cell attachment, spreading as well as migration. In addition, the transcription, secretion and activation of matrix metalloproteinases (MMPs) induced by transforming growth factor-β1 (TGF-β1) in BCPAP cells were mitigated upon curcumin treatment. Further evidence showed that curcumin decreased TGF-β1-mediated phosphorylation of Smad2 and Smad3. These results revealed that curcumin inhibited the TGF-β1-induced epithelial-mesenchymal transition (EMT) via down-regulation of Smad2/3 signaling pathways. Our findings provide new evidence that the anti-metastatic and anti-EMT activities of curcumin may contribute to the development of chemo-preventive agents for thyroid cancer treatment.

摘要

甲状腺癌通常预后良好,但其复发和转移风险却是一个令人困扰的问题。姜黄素[双(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮]是一种主要存在于姜黄(姜黄属植物)中的天然多酚化合物。我们之前的研究表明,姜黄素对K1乳头状甲状腺癌细胞具有增殖抑制和凋亡诱导作用。然而,姜黄素对甲状腺癌细胞抑制作用的潜在机制仍不清楚。在此,我们证明姜黄素显著增加人乳头状甲状腺癌BCPAP细胞中上皮标志物E-钙黏蛋白的表达,并抑制间充质标志物波形蛋白的表达。姜黄素还抑制BCPAP细胞的多个转移步骤,包括细胞黏附、铺展以及迁移。此外,姜黄素处理后,BCPAP细胞中由转化生长因子-β1(TGF-β1)诱导的基质金属蛋白酶(MMPs)的转录、分泌和激活均得到缓解。进一步的证据表明,姜黄素降低了TGF-β1介导的Smad2和Smad3的磷酸化。这些结果表明,姜黄素通过下调Smad2/3信号通路抑制TGF-β1诱导的上皮-间质转化(EMT)。我们的研究结果提供了新的证据,表明姜黄素的抗转移和抗EMT活性可能有助于开发用于甲状腺癌治疗的化学预防剂。

相似文献

1
Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.姜黄素通过下调TGF-β/Smad2/3信号通路抑制人甲状腺乳头状癌BCPAP细胞的转移。
Exp Cell Res. 2016 Feb 15;341(2):157-65. doi: 10.1016/j.yexcr.2016.01.006. Epub 2016 Jan 27.
2
Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells.姜黄素抑制 K1 甲状腺乳头状癌细胞的侵袭和转移。
Food Chem. 2013 Aug 15;139(1-4):1021-8. doi: 10.1016/j.foodchem.2013.02.016. Epub 2013 Feb 16.
3
5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.5'-腺苷酸激活蛋白激酶调节甲状腺乳头状癌(TPC-1和BCPAP)细胞的存活、迁移、侵袭及上皮-间质转化
Thyroid. 2016 Jul;26(7):933-42. doi: 10.1089/thy.2015.0440. Epub 2016 Jun 3.
4
Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.沉默 SIX1 通过调控 TGF-β/Smad2/3 信号通路抑制甲状腺乳头状癌细胞上皮间质转化。
Auris Nasus Larynx. 2021 Jun;48(3):487-495. doi: 10.1016/j.anl.2020.10.002. Epub 2020 Oct 17.
5
Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.姜黄素通过抑制 Hedgehog 信号通路逆转胰腺癌细胞的上皮-间充质转化。
Oncol Rep. 2013 Jun;29(6):2401-7. doi: 10.3892/or.2013.2385. Epub 2013 Apr 4.
6
Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.α-硫辛酸抑制甲状腺癌细胞的增殖和上皮-间质转化。
Mol Cell Endocrinol. 2016 Jan 5;419:113-23. doi: 10.1016/j.mce.2015.10.005. Epub 2015 Oct 14.
7
Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.罗格列酮,一种过氧化物酶体增殖物激活受体-γ激动剂,通过抑制 p38 MAPK 信号通路抑制甲状腺乳头状癌细胞迁移和侵袭。
Endocrinol Metab (Seoul). 2021 Oct;36(5):1095-1110. doi: 10.3803/EnM.2021.1155. Epub 2021 Oct 14.
8
EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.EGCG 通过抑制 Smad2 和 Erk1/2 信号通路抑制非小细胞肺癌细胞中的转化生长因子-β介导的上皮-间充质转化。
J Agric Food Chem. 2012 Oct 3;60(39):9863-73. doi: 10.1021/jf303690x. Epub 2012 Sep 19.
9
Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways.安络小皮伞素C通过抑制Smad2/3和β-连环蛋白信号通路抑制乳腺癌细胞的上皮-间质转化和转移。
PLoS One. 2015 Feb 6;10(2):e0117111. doi: 10.1371/journal.pone.0117111. eCollection 2015.
10
Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.辛伐他汀减轻转化生长因子-β1诱导的人肺泡上皮细胞上皮-间质转化。
Cell Physiol Biochem. 2013;31(6):863-74. doi: 10.1159/000350104. Epub 2013 Jun 11.

引用本文的文献

1
Targeting the Purinergic Axis with Phenolic Compounds to Disrupt the Oxidative-Inflammatory Cycle in Thyroid Cancer.用酚类化合物靶向嘌呤能轴以破坏甲状腺癌中的氧化-炎症循环。
Int J Mol Sci. 2025 Aug 31;26(17):8474. doi: 10.3390/ijms26178474.
2
: An anti-cancer traditional Chinese medicine.一种抗癌中药。
Chin Herb Med. 2025 Apr 24;17(3):428-447. doi: 10.1016/j.chmed.2025.04.006. eCollection 2025 Jul.
3
The Effect of Curcumin on the Activity of MMP-17 and MMP-24 in Hepatocytes of Mice Exposed to Thioacetamide.姜黄素对硫代乙酰胺暴露小鼠肝细胞中MMP - 17和MMP - 24活性的影响
Rep Biochem Mol Biol. 2024 Oct;13(3):329-340. doi: 10.61186/rbmb.13.3.329.
4
Kaempferol Targets Global Epigenetic Modifiers to Impedes Growth and Migratory Ability of HeLa Cells.山奈酚靶向全局表观遗传修饰因子以抑制HeLa细胞的生长和迁移能力。
J Cell Mol Med. 2025 Apr;29(7):e70498. doi: 10.1111/jcmm.70498.
5
pH-responsive niosome-based nanocarriers of antineoplastic agents.基于pH响应性非离子表面活性剂囊泡的抗肿瘤药物纳米载体
RSC Adv. 2024 Apr 11;14(16):11124-11140. doi: 10.1039/d4ra01334d. eCollection 2024 Apr 3.
6
The Role of Macrophages in Lung Fibrosis and the Signaling Pathway.巨噬细胞在肺纤维化中的作用及其信号通路。
Cell Biochem Biophys. 2024 Jun;82(2):479-488. doi: 10.1007/s12013-024-01253-5. Epub 2024 Mar 27.
7
The Extraction, Determination, and Bioactivity of Curcumenol: A Comprehensive Review.姜烯酚的提取、测定与生物活性:全面综述。
Molecules. 2024 Jan 30;29(3):656. doi: 10.3390/molecules29030656.
8
Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy.姜黄素在乳腺癌治疗中通过中和肿瘤相关炎症和重编程癌相关成纤维细胞。
Sci Rep. 2023 Nov 26;13(1):20770. doi: 10.1038/s41598-023-48073-w.
9
TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer.转化生长因子-β(TGF-β)与结直肠癌的肿瘤进展、免疫抑制和靶向治疗的相关性。
Med Oncol. 2023 Oct 19;40(11):335. doi: 10.1007/s12032-023-02204-5.
10
Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.天然化合物对肿瘤血管生成、侵袭和转移中缺氧诱导因子-1 信号通路的调控:全面而批判性的综述。
Cancer Metastasis Rev. 2024 Mar;43(1):501-574. doi: 10.1007/s10555-023-10136-9. Epub 2023 Oct 4.